Literature DB >> 1371258

Expression of interleukin-1 (IL-1) beta messenger ribonucleic acid (mRNA) and IL-1 receptor antagonist mRNA in peritoneal macrophages from patients with endometriosis.

H Mori1, M Sawairi, M Nakagawa, N Itoh, K Wada, T Tamaya.   

Abstract

OBJECTIVE: To investigate the expression of interleukin-1 (IL-1) beta messenger ribonucleic acid (mRNA) and IL-1 receptor antagonist (IL-1ra) mRNA in peritoneal macrophages. DESIGN,
SETTING: Peritoneal fluid (PF) samples were collected from patients who underwent laparoscopy or laparotomy. Northern blot analysis was performed at the reproductive research laboratory. PATIENTS: Twenty-six patients with endometriosis, 10 patients with postinflammatory pelvic adhesion, and 12 control women with normal pelvis. MAIN OUTCOME MEASURE: Polyadenylated RNA isolated from peritoneal macrophages was analyzed on Northern blots by using synthetic oligonucleotide probes.
RESULTS: The level of IL-1 beta mRNA expression was elevated in the group with stage I endometriosis, whereas the increased expression of IL-1ra mRNA was observed in the group with stages III and IV endometriosis. The level of IL-1 beta mRNA showed a positive correlation with that of IL-1 beta in PF and a negative correlation with the level of IL-1ra mRNA.
CONCLUSIONS: Our results suggest that peritoneal macrophages express IL-1ra mRNA rather than IL-1 beta mRNA with the progress of endometriosis and that peritoneal macrophages may secrete IL-1ra protein that modulates the effects of IL-1.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371258     DOI: 10.1016/s0015-0282(16)54896-1

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  7 in total

1.  Polymorphisms for interleukin-1 beta (IL-1 beta)-511 promoter, IL-1 beta exon 5, and IL-1 receptor antagonist: nonassociation with endometriosis.

Authors:  Y Y Hsieh; C C Chang; F J Tsai; J Y Wu; Y R Shi; H D Tsai; C H Tsai
Journal:  J Assist Reprod Genet       Date:  2001-09       Impact factor: 3.412

2.  Expression of interleukin-1 (IL-1) ligands system in the most common endometriosis-associated ovarian cancer subtypes.

Authors:  Mamadou Keita; Paul Bessette; Manuella Pelmus; Youssef Ainmelk; Aziz Aris
Journal:  J Ovarian Res       Date:  2010-01-28       Impact factor: 4.234

3.  Antibiotic therapy with metronidazole reduces endometriosis disease progression in mice: a potential role for gut microbiota.

Authors:  Sangappa B Chadchan; Meng Cheng; Lindsay A Parnell; Yin Yin; Andrew Schriefer; Indira U Mysorekar; Ramakrishna Kommagani
Journal:  Hum Reprod       Date:  2019-06-04       Impact factor: 6.918

4.  Interleukin-1β inhibits estrogen receptor-α, progesterone receptors A and B and biomarkers of human endometrial stromal cell differentiation: implications for endometriosis.

Authors:  Jie Yu; Sarah L Berga; Wei Zou; Robert N Taylor
Journal:  Mol Hum Reprod       Date:  2019-10-28       Impact factor: 4.025

5.  PPAR-gamma receptor ligand induces regression of endometrial explants in baboons: a prospective, randomized, placebo- and drug-controlled study.

Authors:  Dan I Lebovic; Jason M Mwenda; Daniel C Chai; Michael D Mueller; Allessandro Santi; Senait Fisseha; Thomas D'Hooghe
Journal:  Fertil Steril       Date:  2007-05-11       Impact factor: 7.329

6.  The diagnostic role of cervico-vaginal fluid interleukins-1α in endometriosis: A case-control study.

Authors:  Farahnaz Mardanian; Zahra Sheikh-Soleimani
Journal:  J Res Med Sci       Date:  2014-12       Impact factor: 1.852

7.  The remedial effect of soluble interleukin-1 receptor type II on endometriosis in the nude mouse model.

Authors:  Liying Gao; Liang Sun; Yugui Cui; Zhen Hou; Li Gao; Jing Zhou; Yundong Mao; Suping Han; Jiayin Liu
Journal:  J Biomed Res       Date:  2010-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.